Our Saviors Lutheran Church
Goal: Share the story of Jesus and the ELCA by engaging with 1 million new people as we grow the church together. Purpose: Activate each of us so more people know the way of Jesus and discover community, justice and love. Vision: A world experiencing the difference God?s grace and love in Christ make for all people and creation.
ICO
420725211
Web
Sign in to see organisation website
Traffic
59409
From Social media
News about from their social media (Facebook and X).
Data about organisation
Interesting nearby
Interesting organisations close by to residence of Our Saviors Lutheran Church
More Interesting nearbySimilar traffic
Organisations with similar web traffic to Our Saviors Lutheran Church
Similar trafficJoin us and make a difference for the future!
Transparent, useful, and beautifully designed.
Yvette
Like Wikipedia for nonprofits — but even more inspiring.
Eve
Transparent, useful, and beautifully designed.
Paul
The idea behind Eduo is genius — let the community build and improve profiles of nonprofit organizations worldwide. It creates trust and motivates engagement.
Patrick
Finally, a clear and organized way to explore local and global charities.
Catherine
I stumbled on Eduo by accident and ended up spending hours learning about different charities across the world. It’s like a global map of goodness
Janet
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Petr
2025-10-25
"Art can be a healing force—Farahana Kassam's inspiring journey from breast cancer survivor to powerful storyteller reminds us of the resilience of the human spirit! 💪🎨 #Hope #ArtHeals #CancerSurvivor"
Discover how art narrates the powerful stories of breast cancer survivors
NBC 5 Dallas-Fort Worth
Like Comment
Joanna
2025-10-25
Exciting news in the fight against Sjögren's disease! 🎉 Nipocalimab showed significant promise in reducing disease activity and severity in a recent study. This breakthrough from Johnson & Johnson gives hope to many patients in the Czech Republic and beyond. Let's celebrate advancements in healthcare! 💪💙 #GoodNews #HealthInnovation #SjögrensDisease
Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies - Johnson & Johnson (NYSE:JNJ)
Benzinga
Like Comment